LEQVIO
Live / Registered — Registered (as of 01 Jan 2019)
What this means for you
Registered since 01 Jan 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79238111
- Registration number
- 5640111
- Mark type
- Stylized text
- Filed
- 30 May 2018
- Published for opposition
- 16 Oct 2018
- Registered
- 01 Jan 2019
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: [ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; ] cardiovascular pharmaceuticals; [ dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; ] pharmaceutical preparations for the prevention and treatment of diseases and disorders of [ the autoimmune system,] the metabolic system [ , the endocrine system, the musculo-skeletal system and the genitourinary system ] ; pharmaceutical preparations for use in hematology; [ and in tissue and organ transplantation; ] [ pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; ] pharmaceutical preparations for the prevention and treatment of hypertension; [ pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 12 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 13 Aug 2024 — INTERNATIONAL REGISTRATION RENEWED
- 30 Jul 2024 — OFFICE ACTION ISSUED POU1
- 25 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Jul 2024 — TEAS SECTION 71 RECEIVED
- 12 Apr 2019 — NOTIFICATION PROCESSED BY IB
- 08 Feb 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 08 Feb 2019 — FINAL DISPOSITION PROCESSED
- 31 Jan 2019 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 01 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
- 09 Nov 2018 — NOTIFICATION PROCESSED BY IB
- 16 Oct 2018 — PUBLISHED FOR OPPOSITION
- 26 Sept 2018 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 26 Sept 2018 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 26 Sept 2018 — NOTICE OF PUBLICATION